(Q39746020)

14 September 2017

A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines (English)

1 reference

14 September 2017

8

1 reference

14 September 2017

Robert-Alain Toillon

9

0 references

author name string

Anne Vessières

1

1 reference

14 September 2017

Cyril Corbet

2

1 reference

14 September 2017

Jan Martin Heldt

3

1 reference

14 September 2017

Nicolas Lories

4

1 reference

14 September 2017

Nathalie Jouy

5

1 reference

14 September 2017

Ioanna Laïos

6

1 reference

14 September 2017

Guy Leclercq

7

1 reference

14 September 2017

7 January 2010

1 reference

Journal of Inorganic Biochemistry

14 September 2017

1 reference

14 September 2017

104

1 reference

14 September 2017

5

1 reference

14 September 2017

503-511

1 reference

Relevance of breast cancer cell lines as models for breast tumours: an update

14 September 2017

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1023/B:BREA.0000014042.54925.CC

Ferrocifens and Ferrocifenols as New Potential Weapons against Breast Cancer

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.2533/CHIMIA.2007.716

COCI

reference URL

Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor

8 July 2023

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/1535-7163.MCT-07-0434

Identifiers

DOI

10.1016/J.JINORGBIO.2009.12.020

1 reference

14 September 2017

1 reference